Developing new models for cancer research and treatment
Official title: Pilot Projects-Tran-Network
Funded at University of Pennsylvania · NIH-10881948 · Data updated 2026-11-12
This study is all about finding new ways to improve cancer research by using special models that come from patients, and it's designed to help researchers create better treatments that can make a real difference for people facing cancer, especially those who might not have the same access to care.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pennsylvania NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project start | July 5, 2023 |
| Project end | June 30, 2028 |
| Funding year | 2024 |
| Award (this year) | $156,303 |
| NIH project number | 5U54CA283759-02 |
| Project ID | NIH-10881948 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals diagnosed with various types of cancer who may benefit from innovative treatment approaches.
✕Less likely to help
Patients with non-cancerous conditions or those not seeking experimental treatment options may not receive benefits from this research.
What this research studies
This research focuses on creating and supporting innovative pilot projects that aim to enhance patient-derived xenograft (PDX) models, which are crucial for cancer research. By fostering collaborations and integrating new technologies, the project seeks to translate basic scientific discoveries into clinical applications that can improve cancer treatment. The initiative will prioritize projects that address cancer disparities and have the potential for significant impact on patient care. Researchers will work closely with the Pilot Project Principal Investigators to develop applications for further funding and support.
Why it matters
Potential benefit: If successful, this research could lead to more effective cancer treatments tailored to individual patients.
How similar studies have gone: Previous research has shown success in developing PDX models for cancer, indicating that this approach has the potential for impactful outcomes.
Where this research is happening
-
University of Pennsylvania
Philadelphia, United States Active
Researchers
- Principal investigator: Skuli, Nicolas — University of Pennsylvania
- Study coordinator: Skuli, Nicolas
Related research
Other NIH-funded projects on the same topics.
-
Comparing universal and guideline-directed genetic testing for young adults with cancer
This study is looking at whether a broader genetic test can help young adults with cancer find inherited risks that regular tests might miss, so they can get better treatment and care tailored just for them.
-
Better, searchable data for human pain biology
A data integration center will standardize, combine, and share molecular and cellular data from human pain research to help scientists understand how pain works and to accelerate discoveries.
-
Understanding how sweat glands form and work to help burn and skin injury patients
A study at the University of Pennsylvania looks at how sweat glands develop and function, with the goal of informing treatments for people who suffer traumatic skin injuries.
-
Cardiovascular risk planning and reduction for men with prostate cancer
A program to better predict and reduce heart disease risk in men treated for prostate cancer, especially older patients.
-
Understanding how a special airway cell helps protect and repair breathing passages
A researcher is studying a newly found airway cell called the hillock to see how it protects the airways and helps repair them after injury, with the aim of helping people with asthma, COPD, or bronchiectasis.
-
Defining TMJ cartilage progenitors and their regulatory niche for TMJ regeneration
Researchers are studying the cells that could help repair the jaw’s cartilage in TMJ osteoarthritis to lay the groundwork for regenerative therapies.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.